VERV / Verve Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Verve Therapeutics, Inc.
US ˙ NasdaqGS ˙ US92539P1012
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier13.917.858 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Verve Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VERV / Verve Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-05-14 Ashe Andrew D. 76.000 6,2600 76.000 6,2600 475.760 267 8.6300 180.120 37,86
2023-12-01 Yeshwant Krishna 1.800.000 10,0000 1.800.000 10,0000 18.000.000
2022-05-12 ADELMAN BURT A 10.000 12,1526 10.000 12,1526 121.526
2022-03-15 ADELMAN BURT A 4.000 21,3838 4.000 21,3838 85.535
2021-12-02 Ashe Andrew D. 4.000 32,1049 4.000 32,1049 128.420
2021-12-02 ADELMAN BURT A 4.700 31,3412 4.700 31,3412 147.304
2021-06-21 Redmile Group, LLC 1.050.000 19,0000 1.050.000 19,0000 19.950.000
2021-06-21 Rock Springs Capital Management LP 370.000 19,0000 370.000 19,0000 7.030.000
2021-06-21 Novo A/S 350.000 19,0000 350.000 19,0000 6.650.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VERV / Verve Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VERV / Verve Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-04-02 Kathiresan Sekar 9.822 4,1500 9.822 4,1500 40.761 6 2.9700 -11.590 -28,43
2025-04-02 Politi Jason 3.235 4,1500 3.235 4,1500 13.425
2025-04-02 Dorval Allison 3.350 4,1500 3.350 4,1500 13.902
2025-04-02 Nickerson Joan 2.777 4,1500 2.777 4,1500 11.525
2025-04-02 Lister Troy 2.189 4,1500 2.189 4,1500 9.084
2025-04-02 Ashe Andrew D. 2.681 4,1500 2.681 4,1500 11.126
2024-12-02 Dorval Allison 555 5,6400 555 5,6400 3.130
2024-04-02 Nickerson Joan 1.514 8,2400 1.514 8,2400 12.475
2023-11-29 Dorval Allison 554 11,4500 554 11,4500 6.343

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VERV / Verve Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-07-28 2025-07-25 4 GV 2017 GP, L.L.C. By GV 2023, L.P. VERV Common Stock U - Other I -1.800.000 0
2025-07-28 2025-07-25 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock U - Other I -4.260.047 0
2025-07-28 2025-07-25 4 GV 2017 GP, L.L.C. By GV 2017 L.P. VERV Common Stock U - Other I -6.108.442 0
2025-07-28 2025-07-25 4 Politi Jason VERV Common Stock U - Other D -16.405 0
2025-07-28 2025-07-25 4 Ashe Andrew D. VERV Common Stock U - Other D -348.828 0
2025-07-28 2025-07-25 4 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock U - Other I -428.326 0
2025-07-28 2025-07-25 4 Lister Troy VERV Common Stock U - Other D -6.952 0
2025-07-28 2025-07-25 4 Kathiresan Sekar Kathiresan Family 2021 Irrevocable Trust VERV Common Stock U - Other I -240.997 0
2025-07-28 2025-07-25 4 Kathiresan Sekar Sekar Kathiresan 2021 Irrevocable Trust VERV Common Stock U - Other I -110.997 0
2025-07-28 2025-07-25 4 Kathiresan Sekar VERV Common Stock U - Other D -348.431 0
2025-07-28 2025-07-25 4 Nickerson Joan VERV Common Stock U - Other D -17.420 0
2025-07-28 2025-07-25 4 Dorval Allison VERV Common Stock U - Other D -13.280 0
2025-07-28 2025-07-25 4 Yeshwant Krishna By GV 2023, L.P. VERV Common Stock U - Other I -1.800.000 0
2025-07-28 2025-07-25 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock U - Other I -4.260.047 0
2025-07-28 2025-07-25 4 Yeshwant Krishna By GV 2017 L.P. VERV Common Stock U - Other I -6.108.442 0
2025-04-03 2025-04-02 4 Lister Troy VERV Common Stock S - Sale D 4,1500 -2.189 -9 6.952
2025-04-03 2025-04-01 4 Lister Troy VERV Common Stock M - Exercise D 7.340 9.141
2025-04-03 2025-04-02 4 Dorval Allison VERV Common Stock S - Sale D 4,1500 -3.350 -14 13.280
2025-04-03 2025-04-01 4 Dorval Allison VERV Common Stock M - Exercise D 11.250 16.630
2025-04-03 2025-04-02 4 Politi Jason VERV Common Stock S - Sale D 4,1500 -3.235 -13 14.226
2025-04-03 2025-04-01 4 Politi Jason VERV Common Stock M - Exercise D 8.815 17.461
2025-04-03 2025-04-02 4 Ashe Andrew D. VERV Common Stock S - Sale D 4,1500 -2.681 -11 348.828
2025-04-03 2025-04-01 4 Ashe Andrew D. VERV Common Stock M - Exercise D 9.000 351.509
2025-04-03 2025-04-02 4 Nickerson Joan VERV Common Stock S - Sale D 4,1500 -2.777 -12 17.420
2025-04-03 2025-04-01 4 Nickerson Joan VERV Common Stock M - Exercise D 9.315 20.197
2025-04-03 2025-04-02 4 Kathiresan Sekar VERV Common Stock S - Sale D 4,1500 -9.822 -41 346.686
2025-04-03 2025-04-01 4 Kathiresan Sekar VERV Common Stock M - Exercise D 33.000 356.508
2024-12-04 2024-12-04 4 Kathiresan Sekar Sekar Kathiresan 2021 Irrevocable Trust VERV Common Stock G - Gift I 30.000 110.997
2024-12-04 2024-12-04 4 Kathiresan Sekar VERV Common Stock G - Gift D -30.000 323.508
2024-12-03 2024-12-02 4 Dorval Allison VERV Common Stock S - Sale D 5,6400 -555 -3 5.380
2024-12-03 2024-11-29 4 Dorval Allison VERV Common Stock M - Exercise D 1.875 5.935
2024-07-02 2024-06-28 4 Kathiresan Sekar VERV Common Stock M - Exercise D 2,8700 30.000 86 351.128
2024-06-28 3 Politi Jason VERV Common Stock D 6.266
2024-06-25 3 Lister Troy VERV Common Stock D 1.801
2024-05-15 2024-05-14 4 Ashe Andrew D. VERV Common Stock P - Purchase D 6,2600 76.000 476 342.509
2024-04-03 2024-04-02 4 Nickerson Joan VERV Common Stock S - Sale D 8,2400 -1.514 -12 8.659
2024-04-03 2024-04-01 4 Nickerson Joan VERV Common Stock M - Exercise D 3.315 10.173
2024-02-09 2023-09-18 5 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock G - Gift I 37.168 428.326
2024-02-09 2023-09-18 5 ADELMAN BURT A Burt A Adelman 2021 GRAT VERV Common Stock G - Gift I -37.168 0
2024-02-09 2023-08-11 5 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock G - Gift I 266.258 391.158
2024-02-09 2023-08-11 5 ADELMAN BURT A Burt A Adelman 2021 GRAT VERV Common Stock G - Gift I -266.258 37.168
2024-02-09 2022-11-07 5 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock G - Gift I 106.200 124.900
2024-02-09 2022-11-07 5 ADELMAN BURT A Burt A Adelman 2021 GRAT VERV Common Stock G - Gift I -106.200 303.426
2023-12-05 3 GV 2023 GP, L.L.C. By GV 2023, L.P. VERV Common Stock I 1.800.000
2023-12-05 2023-12-01 4 Yeshwant Krishna By GV 2023, L.P. VERV Common Stock P - Purchase I 10,0000 1.800.000 18.000 1.800.000
2023-12-01 2023-11-29 4 Dorval Allison VERV Common Stock S - Sale D 11,4500 -554 -6 4.060
2023-12-01 2023-11-29 4 Dorval Allison VERV Common Stock M - Exercise D 1.875 4.614
2023-02-23 3 Nickerson Joan VERV Common Stock D 5.494
2022-12-16 2022-12-14 4 Bellinger Andrew VERV Common Stock M - Exercise D 2,8700 36.000 103 42.629
2022-12-02 2022-12-01 4 Bellinger Andrew VERV Common Stock S - Sale D 22,9500 -865 -20 6.629
2022-12-01 2022-11-29 4 Dorval Allison VERV Common Stock S - Sale D 22,1000 -554 -12 2.186
2022-12-01 2022-11-29 4 Dorval Allison VERV Common Stock M - Exercise D 1.875 2.740
2022-11-08 2022-11-04 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 32,9000 -243 -8 4.260.047
2022-11-08 2022-11-04 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 31,9905 -650 -21 4.260.290
2022-11-08 2022-11-04 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 31,1180 -47.690 -1.484 4.260.940
2022-11-08 2022-11-04 4 Yeshwant Krishna By GV 2017 L.P. VERV Common Stock J - Other I -48.583 6.108.442
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 32,9000 -243 -8 4.260.047
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 31,9905 -650 -21 4.260.290
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 31,1180 -47.690 -1.484 4.260.940
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 31,1180 -47.690 -1.484 4.260.940
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 32,9000 -242 -8 0
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 31,9905 -651 -21 242
2022-11-08 2022-11-04 4 GV 2017 GP, L.L.C. By GV 2017 L.P. VERV Common Stock J - Other I -48.583 6.108.442
2022-11-04 2022-11-03 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 33,8373 -1.755 -59 4.308.630
2022-11-04 2022-11-03 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 33,1384 -25.534 -846 4.310.385
2022-11-04 2022-11-03 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 32,3155 -22.279 -720 4.335.919
2022-11-04 2022-11-03 4 Yeshwant Krishna By GV 2017 L.P. VERV Common Stock J - Other I -49.569 6.157.025
2022-11-04 2022-11-02 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 36,7750 -8.930 -328 4.358.198
2022-11-04 2022-11-02 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 36,2786 -10.372 -376 4.367.128
2022-11-04 2022-11-02 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 34,7754 -9.350 -325 4.377.500
2022-11-04 2022-11-02 4 Yeshwant Krishna By GV 2017 L.P. VERV Common Stock J - Other I -28.651 6.206.594
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 33,8373 -1.755 -59 4.308.630
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 33,8373 -1.755 -59 4.308.630
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 33,1384 -25.534 -846 4.310.385
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 32,3155 -22.279 -720 4.335.919
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 32,3155 -22.279 -720 4.335.919
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 33,1384 -25.535 -846 1.755
2022-11-04 2022-11-03 4 GV 2017 GP, L.L.C. By GV 2017 L.P. VERV Common Stock J - Other I -49.569 6.157.025
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 36,7750 -8.930 -328 4.358.198
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 36,7750 -8.930 -328 4.358.198
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 36,2786 -10.372 -376 4.367.128
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 36,2786 -10.372 -376 4.367.128
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 34,7754 -9.350 -325 4.377.500
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 34,7754 -9.349 -325 19.302
2022-11-04 2022-11-02 4 GV 2017 GP, L.L.C. By GV 2017 L.P. VERV Common Stock J - Other I -28.651 6.206.594
2022-11-02 2022-11-01 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 38,6385 -260 -10 4.386.850
2022-11-02 2022-11-01 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 37,8210 -2.377 -90 4.387.110
2022-11-02 2022-11-01 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 36,6878 -29.326 -1.076 4.389.487
2022-11-02 2022-11-01 4 Yeshwant Krishna By GV 2017 L.P. VERV Common Stock J - Other I -31.963 6.235.245
2022-11-02 2022-10-31 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 40,6445 -88 -4 4.418.813
2022-11-02 2022-10-31 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 40,1569 -6.601 -265 4.418.901
2022-11-02 2022-10-31 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 38,9432 -23.275 -906 4.425.502
2022-11-02 2022-10-31 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock S - Sale I 37,9061 -23.732 -900 4.448.777
2022-11-02 2022-10-31 4 Yeshwant Krishna By GV 2017 L.P. VERV Common Stock J - Other I -53.697 6.267.208
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 38,6385 -260 -10 4.386.850
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 38,6385 -260 -10 4.386.850
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 37,8210 -2.377 -90 4.387.110
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 37,8210 -2.377 -90 4.387.110
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 36,6878 -29.326 -1.076 4.389.487
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 36,6878 -29.326 -1.076 4.389.487
2022-11-02 2022-11-01 4 GV 2017 GP, L.L.C. By GV 2017 L.P. VERV Common Stock J - Other I -31.963 6.235.245
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 40,6445 -88 -4 4.418.813
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 40,6445 -88 -4 4.418.813
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 40,1569 -6.601 -265 4.418.901
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 40,1569 -6.601 -265 4.418.901
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 38,9432 -23.275 -906 4.425.502
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 37,9061 -23.732 -900 4.448.777
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By GV 2019 L.P. VERV Common Stock S - Sale I 37,9061 -23.732 -900 4.448.777
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By Alphabet Holdings LLC VERV Common Stock S - Sale I 38,9432 -23.276 -906 6.689
2022-11-02 2022-10-31 4 GV 2017 GP, L.L.C. By GV 2017 L.P. VERV Common Stock J - Other I -53.697 6.267.208
2022-11-01 2022-10-28 4 Bellinger Andrew VERV Common Stock S - Sale D 39,9000 -10.000 -399 6.629
2022-11-01 2022-10-28 4 Bellinger Andrew VERV Common Stock M - Exercise D 1,4800 10.000 15 16.629
2022-10-05 2022-10-03 4 Kathiresan Sekar VERV Common Stock S - Sale D 34,9723 -9.904 -346 317.839
2022-10-05 2022-10-03 4 Kathiresan Sekar VERV Common Stock S - Sale D 34,1296 -11.185 -382 327.743
2022-10-05 2022-10-03 4 Kathiresan Sekar VERV Common Stock S - Sale D 33,0157 -28.911 -955 338.928
2022-10-05 2022-10-03 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 50.000 70 367.839
2022-09-27 2022-09-23 4 Bellinger Andrew VERV Common Stock S - Sale D 36,0336 -3.202 -115 6.629
2022-09-27 2022-09-23 4 Bellinger Andrew VERV Common Stock S - Sale D 35,3091 -36.798 -1.299 9.831
2022-09-27 2022-09-23 4 Bellinger Andrew VERV Common Stock M - Exercise D 1,4800 40.000 59 46.629
2022-09-27 2022-09-23 4 Bellinger Andrew VERV Common Stock S - Sale D 35,5927 -13.368 -476 6.629
2022-09-27 2022-09-23 4 Bellinger Andrew VERV Common Stock S - Sale D 34,6660 -6.632 -230 19.997
2022-09-27 2022-09-23 4 Bellinger Andrew VERV Common Stock M - Exercise D 1,4800 20.000 30 26.629
2022-08-29 2022-08-25 4 Ashe Andrew D. VERV Common Stock M - Exercise D 2,8700 10.835 31 266.509
2022-08-29 2022-08-25 4 Ashe Andrew D. VERV Common Stock M - Exercise D 1,4800 33.749 50 255.674
2022-08-29 2022-08-25 4 Ashe Andrew D. VERV Common Stock M - Exercise D 1,3900 51.203 71 221.925
2022-08-11 2022-08-10 4 Kathiresan Sekar VERV Common Stock S - Sale D 29,9000 -50.000 -1.495 317.839
2022-08-11 2022-08-10 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 50.000 70 367.839
2022-07-22 2022-07-20 4 Bellinger Andrew VERV Common Stock S - Sale D 34,9000 -20.000 -698 6.629
2022-07-22 2022-07-20 4 Bellinger Andrew VERV Common Stock M - Exercise D 1,3900 20.000 28 26.629
2022-07-21 2022-07-19 4 Kathiresan Sekar VERV Common Stock S - Sale D 29,9000 -50.000 -1.495 317.839
2022-07-21 2022-07-19 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 50.000 70 367.839
2022-07-15 2022-07-07 4 Kathiresan Sekar Kathiresan Family 2021 Irrevocable Trust VERV Common Stock G - Gift I 160.000 240.997
2022-07-15 2022-07-07 4 Kathiresan Sekar VERV Common Stock G - Gift D -160.000 317.839
2022-07-15 2022-07-13 4 Bellinger Andrew VERV Common Stock S - Sale D 24,9000 -10.000 -249 6.629
2022-07-15 2022-07-13 4 Bellinger Andrew VERV Common Stock M - Exercise D 1,4800 10.000 15 16.629
2022-07-14 2022-07-12 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 22,0400 -63.000 -1.389 570.729
2022-07-14 2022-07-12 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 19,9800 -100.000 -1.998 633.729
2022-07-06 2022-07-01 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 15,6600 -38.775 -607 773.729
2022-07-01 2022-06-30 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 15,2100 -18.810 -286 772.504
2022-07-01 2022-06-29 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 15,6000 -30.362 -474 791.314
2022-07-01 2022-06-29 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 15,5000 -4.047 -63 821.676
2022-05-13 2022-05-12 4 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock P - Purchase I 12,1526 10.000 122 18.700
2022-03-22 2022-03-18 4 Kathiresan Sekar VERV Stock Option (right to buy) M - Exercise D 2,87 -69.674 605.308
2022-03-22 2022-03-18 4 Kathiresan Sekar VERV Common Stock M - Exercise D 2,8700 69.674 200 477.525
2022-03-17 2022-03-15 4 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock P - Purchase I 21,3838 4.000 86 8.700
2022-03-11 2022-03-09 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 29,0100 -3.971 -115 825.723
2022-02-15 2022-02-11 4 Dorval Allison VERV Stock Option (right to buy) A - Award D 30,94 60.000 60.000
2022-02-15 2022-02-11 4 Kathiresan Sekar VERV Stock Option (right to buy) A - Award D 30,94 332.000 332.000
2022-02-15 2022-02-11 4 Bellinger Andrew VERV Stock Option (right to buy) A - Award D 30,94 125.000 125.000
2022-02-15 2022-02-11 4 Ashe Andrew D. VERV Stock Option (right to buy) A - Award D 30,94 125.000 125.000
2022-02-11 2022-02-09 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 29,4600 -13.190 -389 829.694
2022-02-03 2022-02-01 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 29,0400 -35.574 -1.033 842.884
2022-01-28 2022-01-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 30,0200 -247 -7 878.458
2022-01-28 2022-01-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 29,2600 -8.736 -256 878.705
2022-01-28 2022-01-26 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 31,9600 -45.946 -1.468 887.441
2022-01-28 2022-01-26 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 31,1200 -88.989 -2.769 933.387
2022-01-28 2022-01-26 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock S - Sale I 29,6700 -14.918 -443 1.022.376
2022-01-06 2022-01-04 4 Kathiresan Sekar VERV Stock Option (right to buy) M - Exercise D 1,39 -1.870 267.425
2022-01-06 2022-01-04 4 Kathiresan Sekar VERV Common Stock S - Sale D 39,9000 -1.870 -75 406.536
2022-01-06 2022-01-04 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 1.870 3 408.406
2021-12-29 2021-12-28 4 Kathiresan Sekar VERV Stock Option (right to buy) M - Exercise D 1,39 -6.693 269.295
2021-12-29 2021-12-28 4 Kathiresan Sekar VERV Common Stock S - Sale D 39,9000 -6.693 -267 406.536
2021-12-29 2021-12-28 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 6.693 9 413.229
2021-12-29 2021-12-27 4 Kathiresan Sekar VERV Stock Option (right to buy) M - Exercise D 1,39 -42.000 275.988
2021-12-29 2021-12-27 4 Kathiresan Sekar VERV Common Stock S - Sale D 42,2106 -770 -33 406.536
2021-12-29 2021-12-27 4 Kathiresan Sekar VERV Common Stock S - Sale D 41,2431 -4.787 -197 407.306
2021-12-29 2021-12-27 4 Kathiresan Sekar VERV Common Stock S - Sale D 40,0228 -36.443 -1.459 412.093
2021-12-29 2021-12-27 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 42.000 58 448.536
2021-12-28 3 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock I 1.037.294
2021-12-27 2021-12-22 4 Bellinger Andrew VERV Stock Option (right to buy) M - Exercise D 1,48 -15.000 146.995
2021-12-27 2021-12-22 4 Bellinger Andrew VERV Common Stock S - Sale D 39,3749 -4.871 -192 5.000
2021-12-27 2021-12-22 4 Bellinger Andrew VERV Common Stock S - Sale D 38,6020 -8.161 -315 9.871
2021-12-27 2021-12-22 4 Bellinger Andrew VERV Common Stock S - Sale D 37,4202 -1.968 -74 18.032
2021-12-27 2021-12-22 4 Bellinger Andrew VERV Common Stock M - Exercise D 1,4800 15.000 22 20.000
2021-12-27 2021-12-23 4 Kathiresan Sekar VERV Stock Option (right to buy) M - Exercise D 1,39 -57.000 317.988
2021-12-27 2021-12-23 4 Kathiresan Sekar VERV Common Stock S - Sale D 39,9000 -57.000 -2.274 406.536
2021-12-27 2021-12-23 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 57.000 79 463.536
2021-12-27 2021-12-22 4 Kathiresan Sekar VERV Stock Option (right to buy) M - Exercise D 1,39 -57.000 374.988
2021-12-27 2021-12-22 4 Kathiresan Sekar VERV Common Stock S - Sale D 39,7783 -3.269 -130 406.536
2021-12-27 2021-12-22 4 Kathiresan Sekar VERV Common Stock S - Sale D 39,0564 -31.139 -1.216 409.805
2021-12-27 2021-12-22 4 Kathiresan Sekar VERV Common Stock S - Sale D 38,3139 -16.718 -641 440.944
2021-12-27 2021-12-22 4 Kathiresan Sekar VERV Common Stock S - Sale D 37,3782 -5.874 -220 457.662
2021-12-27 2021-12-22 4 Kathiresan Sekar VERV Common Stock M - Exercise D 1,3900 57.000 79 463.536
2021-12-17 2021-12-16 4 Bellinger Andrew VERV Stock Option (right to buy) A - Award D 34,88 55.000 55.000
2021-12-06 2021-12-02 4 Ashe Andrew D. VERV Common Stock P - Purchase D 32,1049 4.000 128 170.722
2021-12-06 2021-12-02 4 ADELMAN BURT A Burt A Adelman 2002 Trust VERV Common Stock P - Purchase I 31,3412 4.700 147 4.700
2021-11-30 2021-11-29 4 Dorval Allison VERV Restricted Stock Units A - Award D 7.500 7.500
2021-11-30 2021-11-29 4 Dorval Allison VERV Stock Option (right to buy) A - Award D 33,25 135.000 135.000
2021-06-23 2021-06-21 4 Broad Institute, Inc. VERV Common Stock J - Other D 387.830 809.784
2021-06-23 2021-06-21 4 Beam Therapeutics Inc. VERV Series A Convertible Preferred Stock C - Conversion D -2.508.361 0
2021-06-23 2021-06-21 4 Beam Therapeutics Inc. VERV Common Stock C - Conversion D 270.895 546.970
2021-06-23 2021-06-21 4 ARCH Venture Partners X, LLC See Footnotes VERV Series A-2 Convertible Preferred Stock C - Conversion I -4.508.146 0
2021-06-23 2021-06-21 4 ARCH Venture Partners X, LLC See Footnotes VERV Series A-2 Convertible Preferred Stock C - Conversion I -4.508.144 0
2021-06-23 2021-06-21 4 ARCH Venture Partners X, LLC See Footnotes VERV Series A Convertible Preferred Stock C - Conversion I -7.107.023 0
2021-06-23 2021-06-21 4 ARCH Venture Partners X, LLC See Footnotes VERV Series A Convertible Preferred Stock C - Conversion I -7.107.024 0
2021-06-23 2021-06-21 4 ARCH Venture Partners X, LLC ARCH Venture Fund X Overage, L.P. VERV Common Stock, par value $0.001 C - Conversion I 1.254.405 1.254.405
2021-06-23 2021-06-21 4 ARCH Venture Partners X, LLC ARCH Venture Fund X, L.P. VERV Common Stock, par value $0.001 C - Conversion I 1.254.404 1.254.404
2021-06-23 2021-06-21 4 Redmile Group, LLC VERV Series B Convertible Preferred Stock C - Conversion I -8.208.832 0
2021-06-23 2021-06-21 4 Redmile Group, LLC VERV Common Stock P - Purchase I 19,0000 1.050.000 19.950 1.936.530
2021-06-23 2021-06-21 4 Redmile Group, LLC VERV Common Stock C - Conversion I 886.530 886.530
2021-06-23 2021-06-21 4 Cormorant Asset Management, LLC See Footnotes VERV Series B Convertible Preferred Stock C - Conversion I -709.224 0
2021-06-23 2021-06-21 4 Cormorant Asset Management, LLC See Footnotes VERV Common Stock P - Purchase I 19,0000 275.000 5.225 984.224
2021-06-23 2021-06-21 4 Cormorant Asset Management, LLC See Footnotes VERV Common Stock C - Conversion I 709.224 709.224
2021-06-23 2021-06-21 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Series A Preferred Stock C - Conversion I -8.361.204 0
2021-06-23 2021-06-21 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Series A-2 Preferred Stock C - Conversion I -1.243.626 0
2021-06-23 2021-06-21 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock C - Conversion I 902.986 1.037.294
2021-06-23 2021-06-21 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund V LP VERV Common Stock C - Conversion I 134.308 134.308
2021-06-22 2021-06-21 4 Logos Global Management LP See Footnotes VERV Series B Preferred Stock C - Conversion I -4.104.416 0
2021-06-22 2021-06-21 4 Logos Global Management LP VERV Common Stock P - Purchase D 19,0000 370.000 7.030 370.000
2021-06-22 2021-06-21 4 Logos Global Management LP See Footnotes VERV Common Stock C - Conversion I 443.265 443.265
2021-06-22 2021-06-21 4 GV 2017 GP, L.L.C. By GV 2017, L.P. VERV Series A Preferred Stock C - Conversion I -58.528.428 0
2021-06-22 2021-06-21 4 GV 2017 GP, L.L.C. By GV 2017, L.P. VERV Common Stock C - Conversion I 6.320.905 6.320.905
2021-06-22 2021-06-21 4 Rock Springs Capital Management LP VERV Series B Preferred Stock C - Conversion I -1.416.023 0
2021-06-22 2021-06-21 4 Rock Springs Capital Management LP VERV Series B Preferred Stock C - Conversion I -5.151.043 0
2021-06-22 2021-06-21 4 Rock Springs Capital Management LP VERV Common Stock C - Conversion I 152.926 152.926
2021-06-22 2021-06-21 4 Rock Springs Capital Management LP VERV Common Stock P - Purchase I 19,0000 370.000 7.030 926.298
2021-06-22 2021-06-21 4 Rock Springs Capital Management LP VERV Common Stock C - Conversion I 556.298 556.298
2021-06-22 2021-06-21 4 Novo A/S VERV SERIES B CONVERTIBLE PREFERRED STOCK C - Conversion D -443.265 0
2021-06-22 2021-06-21 4 Novo A/S VERV COMMON STOCK P - Purchase D 19,0000 350.000 6.650 793.265
2021-06-22 2021-06-21 4 Novo A/S VERV COMMON STOCK C - Conversion D 443.265 443.265
2021-06-22 2021-06-21 4 GV 2019 GP, L.L.C. By GV 2019 L.P. VERV Series B Preferred Stock C - Conversion I -4.104.416 0
2021-06-22 2021-06-21 4 GV 2019 GP, L.L.C. By GV 2019 L.P. VERV Series A-2 Preferred Stock C - Conversion I -37.308.792 0
2021-06-22 2021-06-21 4 GV 2019 GP, L.L.C. By GV 2019 L.P. VERV Common Stock C - Conversion I 443.265 4.472.509
2021-06-22 2021-06-21 4 GV 2019 GP, L.L.C. By GV 2019 L.P. VERV Common Stock C - Conversion I 4.029.244 4.029.244
2021-06-22 2021-06-21 4 Yeshwant Krishna By GV 2019 L.P. VERV Series B Preferred Stock C - Conversion I -4.104.416 0
2021-06-22 2021-06-21 4 Yeshwant Krishna By GV 2019 L.P. VERV Series A-2 Preferred Stock C - Conversion I -37.308.792 0
2021-06-22 2021-06-21 4 Yeshwant Krishna By GV 2017, L.P. VERV Series A Preferred Stock C - Conversion I -58.528.428 0
2021-06-22 2021-06-21 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock C - Conversion I 443.265 4.472.509
2021-06-22 2021-06-21 4 Yeshwant Krishna By GV 2019 L.P. VERV Common Stock C - Conversion I 4.029.244 4.029.244
2021-06-22 2021-06-21 4 Yeshwant Krishna By GV 2017, L.P. VERV Common Stock C - Conversion I 6.320.905 6.320.905
2021-06-22 2021-06-21 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. VERV Series B Preferred Stock C - Conversion D -10.671.482 0
2021-06-22 2021-06-21 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. VERV Series A-2 Preferred Stock C - Conversion D -12.436.264 0
2021-06-22 2021-06-21 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. VERV Common Stock C - Conversion D 1.152.490 2.495.571
2021-06-22 2021-06-21 4 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. VERV Common Stock C - Conversion D 1.343.081 1.343.081
2021-06-22 2021-06-21 4 Casdin Partners Master Fund, L.P. VERV Series B Preferred Stock C - Conversion D -2.873.091 0
2021-06-22 2021-06-21 4 Casdin Partners Master Fund, L.P. VERV Series A-2 Preferred Stock C - Conversion D -9.327.198 0
2021-06-22 2021-06-21 4 Casdin Partners Master Fund, L.P. VERV Common Stock P - Purchase D 19,0000 1.100.000 20.900 2.417.596
2021-06-22 2021-06-21 4 Casdin Partners Master Fund, L.P. VERV Common Stock C - Conversion D 310.285 1.317.596
2021-06-22 2021-06-21 4 Casdin Partners Master Fund, L.P. VERV Common Stock C - Conversion D 1.007.311 1.007.311
2021-06-22 2021-06-21 4 Casdin Private Growth Equity Fund, L.P. VERV Series B Preferred Stock C - Conversion D -5.746.183 0
2021-06-22 2021-06-21 4 Casdin Private Growth Equity Fund, L.P. VERV Common Stock C - Conversion D 620.571 620.571
2021-06-21 2021-06-21 4 Beaudoin Margaret VERV Common Stock P - Purchase D 19,0000 1.000 19 1.000
2021-06-21 2021-06-17 4 Beaudoin Margaret VERV Stock Option (right to buy) A - Award D 19,00 10.799 10.799
2021-06-21 2021-06-21 4 Bellinger Andrew VERV Common Stock P - Purchase D 19,0000 5.000 95 5.000
2021-06-21 2021-06-17 4 Bellinger Andrew VERV Stock Option (right to buy) A - Award D 19,00 21.599 21.599
2021-06-21 2021-06-17 4 MacLean Michael F VERV Stock Option (right to buy) A - Award D 19,00 47.664 47.664
2021-06-21 2021-06-21 4 Kathiresan Sekar VERV Common Stock P - Purchase D 19,0000 2.500 48 406.536
2021-06-21 2021-06-17 4 Kathiresan Sekar VERV Stock Option (right to buy) A - Award D 19,00 53.998 53.998
2021-06-21 2021-06-17 4 Ashe Andrew D. VERV Stock Option (right to buy) A - Award D 19,00 21.599 21.599
2021-06-16 3 Beam Therapeutics Inc. VERV Common Stock D 276.075
2021-06-16 3 Joung Jae Keith By Jae Keith Joung 2017 Irrevocable Trust VERV Common Stock I 102.406
2021-06-16 3 Joung Jae Keith By MMK Tech LLC VERV Common Stock I 307.219
2021-06-16 3 Kathiresan Sekar Sekar Kathiresan 2021 Irrevocable Trust VERV Common Stock I 80.997
2021-06-16 3 Kathiresan Sekar VERV Common Stock D 404.036
2021-06-16 3 Kathiresan Sekar Kathiresan Family 2021 Irrevocable Trust VERV Common Stock I 80.997
2021-06-16 3 Rozen Israel VERV Common Stock D 409.626
2021-06-16 3 ADELMAN BURT A The Burt A. Adelman 2021 GRAT VERV Common Stock I 409.626
2021-06-16 3 Ticho Barry VERV Common Stock D 409.626
2021-06-16 3 Ashe Andrew D. VERV Common Stock D 166.722
2021-06-16 3 Broad Institute, Inc. VERV Common Stock D 421.954
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista